Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA476945
Max Phase: Preclinical
Molecular Formula: C19H19N5S
Molecular Weight: 349.46
Molecule Type: Small molecule
Associated Items:
ID: ALA476945
Max Phase: Preclinical
Molecular Formula: C19H19N5S
Molecular Weight: 349.46
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CC(C)c1c(Sc2cccc3ccccc23)[nH]c2nc(N)nc(N)c12
Standard InChI: InChI=1S/C19H19N5S/c1-10(2)14-15-16(20)22-19(21)24-17(15)23-18(14)25-13-9-5-7-11-6-3-4-8-12(11)13/h3-10H,1-2H3,(H5,20,21,22,23,24)
Standard InChI Key: MKRNFARKVGJOOC-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 349.46 | Molecular Weight (Monoisotopic): 349.1361 | AlogP: 4.55 | #Rotatable Bonds: 3 |
Polar Surface Area: 93.61 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 3 |
#RO5 Violations: 0 | HBA (Lipinski): 5 | HBD (Lipinski): 5 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 12.11 | CX Basic pKa: 8.32 | CX LogP: 4.64 | CX LogD: 3.69 |
Aromatic Rings: 4 | Heavy Atoms: 25 | QED Weighted: 0.50 | Np Likeness Score: -0.48 |
1. Gangjee A, Jain HD, Queener SF, Kisliuk RL.. (2008) The effect of 5-alkyl modification on the biological activity of pyrrolo[2,3-d]pyrimidine containing classical and nonclassical antifolates as inhibitors of dihydrofolate reductase and as antitumor and/or antiopportunistic infection agents., 51 (15): [PMID:18605720] [10.1021/jm800244v] |
Source(1):